Chemical, Biochemical, Cellular, and Physiological Characterization of Leucettinib-21, a Down Syndrome and Alzheimer’s Disease Drug Candidate. – Logos Biosystems | Advanced Imaging Solutions for Research Excellence

Lindberg, M. F., Deau, E., Miege, F., Greverie, M., Roche, D., George, N., … & Meijer, L. (2023). Journal of Medicinal Chemistry, 66(23), 15648-15670.

Back